ArticleFrontiers in immunology2026
Predicting major organ complications in primary Sjögren's disease using a machine learning ensemble strategy: a dual-center retrospective clinical study.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Primary Sjögren's disease (SjD) is a systemic autoimmune disease whose major organ complications severely affect patient prognosis. Currently, there is a lack of efficient and accurate tools for early identification of high-risk patients. Methods: This study retrospectively collected clinical data from 232 SjD patients, including demographic characteristics, clinical symptoms, and laboratory indicators. Three machine learning algorithms-logistic regression (LR), support vector machine (SVM), and random forest (RF)-were used to construct prediction models, and a soft voting ensemble strategy was applied to combine model outputs. Feature importance was analyzed using the SHAP framework. Results: The ensemble model performed best on the test set, with an AUC of 0.725, accuracy of 71%, and a negative predictive value (NPV) of 79%. SHAP analysis revealed that complement C3 and immunoglobulin G (IgG) were the most important predictors, with low C3 and high IgG levels significantly associated with complication risk. Conclusion: The ensemble model showed moderate discriminatory performance for identifying major organ complications in SjD using routinely available clinical variables. Complement C3 and IgG were identified as important predictors. The model may serve as a preliminary auxiliary risk-stratification tool, but further external validation and model optimization are required before clinical implementation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.